Osteoporosis: Incidence, prevention, and treatment of the silent killer

Nursing Clinics of North America

Volumn 40, Issue 1, 2005, Pages 119-133

  Parsons, Lynn C ^a  

^a MIDDLE TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTONE; ALENDRONIC ACID; CALCITONIN; CALCIUM; PARATHYROID HORMONE[1-34]; RALOXIFENE; RISEDRONIC ACID; SALCATONIN; VITAMIN D;

ARTHRALGIA; BACKACHE; BONE DENSITY; CORTICOSTEROID INDUCED OSTEOPOROSIS; DEEP VEIN THROMBOSIS; DIARRHEA; DIET SUPPLEMENTATION; DISABILITY; DRUG ERUPTION; DRY NOSE; ESOPHAGITIS; EXERCISE; FALLING; FRACTURE; HEADACHE; HEALTH CARE COST; HEALTH CARE FACILITY; HOSPITALIZATION; HOT FLUSH; HUMAN; HYPOTENSION; LEG CRAMP; LIFESTYLE; LONG TERM CARE; NAUSEA; NURSING HOME; OSTEOPOROSIS; PATHOPHYSIOLOGY; PATIENT EDUCATION; PHYSIOTHERAPY; REVIEW; SEX DIFFERENCE; VERTIGO; WEIGHT BEARING;

EID: 14744295629     PISSN: 00296465     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cnur.2004.09.001     Document Type: Review

References (54)

1. National Osteoporosis Foundation (NOF) Disease statistics 2004 National Osteoporosis Foundation Washington, DC
2. M.T. Lawson Evaluating and managing osteoporosis in men Nurse Pract 26 2001 26 49
3. J.M. Lane, S.N. Khan, and A.D. Diwan Osteoporosis: current clinical trends Clin Geriatr 8 2000 27 39
4. K.A. Geier Osteoporosis in men Orthop Nurs 20 2001 49 56
5. C.A. Sedlak, M.O. Doheny, and P.J. Estok Osteoporosis in older men: knowledge and health beliefs Orthop Nurs 19 2000 38 46
6. National Osteoporosis Foundation (NOF) Osteoporosis - bone health 2004 National Osteoporosis Foundation Washington, DC
7. National Osteoporosis Foundation (NOF) Osteoporosis - what is it? 2004 National Osteoporosis Foundation Washington, DC
8. L.J. Melton III The prevalence of osteoporosis: gender and racial comparison Calcif Tissue Int 69 2001 179 181
9. C. Lewis Osteoporosis and men FDA Consum 36 2002 15 18
10. L.C. Parsons, S.D. Krau, and K.S. Ward Orthopaedic trauma: managing secondary medical problems Crit Care Nurs Clin N Am 13 2001 433 442
11. M.A. Moon Be aware that osteoporosis also affects young women and men Fam Pract News 30 2000 25 29
12. J.R. Taylor, and D. Sicard What pharmacists should know about osteoporosis Drug Topics 147 2003 78 93
13. National Osteoporosis Foundation (NOF) Men with osteoporosis in their own words 2000 National Osteoporosis Foundation Washington DC
14. Harvard Men's Health Watch. Osteoporosis in men, Harv Mens Health Watch 1999;3(7):1-4.
15. C. Crandall Gender differences in osteoporosis treatment: a review of clinical research J Gend Specif Med 3 2000 42 46
16. T.M. Hisel, and B.B. Phillips Update on the treatment of osteoporosis Formulary 38 2003 223 239
17. P. Egger, S. Duggleby, and R. Hobbs Cigarette smoking and bone mineral density in the elderly J Epidemiol Community Health 50 1996 47 50
18. National Osteoporosis Foundation (NOF) Prevention - exercise for healthy bones 2004 National Osteoporosis Foundation Washington, DC
19. T. Spiker Skeleton key: As you read this, your bones are becoming shorter, thinner, and more brittle. Do you know how to stop the decline? Men's Health 17 2002 88 91
20. J. Compston Secondary causes of osteoporosis in men Calcif Tissue Int 69 2001 193 195
21. National Osteoporosis Foundation (NOF) Osteoporosis - bone mass measurement 2004 National Osteoporosis Foundation Washington, DC
22. C. Crandall Osteoporosis in men: where do we stand with screening and treatment Consultant 42 2002 112 119
23. R.A. Wisewell, S.A. Hawkins, and H.C. Dreyer Maintenance of BMD in older male runners is independent of changes in training volume or VO(2) peak J Gerontol A Biol Sci Med 57 2002 203 208
24. S.T. Baskin Osteoporosis: some new diagnostic and treatment options Cleveland Nursing Weekly May 13, 1996
25. P.R. Ebeling, J.D. Wark, and S. Yeung Effects of calcitrol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study J Clin Endocrinol Metab 86 2001 4098 4103
26. M.A. Rodriguez-Martinez, and E.C. Garcia-Cohen Role of Ca (2+) and vitamin D in the prevention and treatment of osteoporosis Pharmacol Ther 93 2002 37 49
27. National Osteoporosis Foundation (NOF) Prevention - who's at risk? 2004 National Osteoporosis Foundation Washington, DC
28. National Osteoporosis Foundation (NOF) Prevention - calcium supplements 2004 National Osteoporosis Foundation Washington, DC
29. National Osteoporosis Foundation (NOF) Prevention - Calcium and Vitamin D 2004 National Osteoporosis Foundation Washington, DC
30. S.L. Tse, T.Y. Chan, and D.M. Wu Deficient dietary vitamin K intake among elderly nursing home residents in Hong Kong Asia Pac J Clin Nutr 11 2002 62 65
31. National Osteoporosis Foundation (NOF) Medications - to prevent and treat osteoporosis 2004 National Osteoporosis Foundation Washington, DC
32. R.A. Lehne Pharmacology for nursing care 5th edition 2004 Saunders Boston, MA
33. K. Gutierrez, and S.F. Queener Pharmacology for nursing practice 2003 Mosby St. Louis, MO
34. National Osteoporosis Foundation (NOF) Physician's guide to prevention and treatment of osteoporosis 2003 National Osteoporosis Foundation Washington, DC
35. S. Adami, R. Prizzi, and F. Colapietro Alendronate for the treatment of osteoporosis in men Calcif Tissue Int 69 2001 239 241
36. J.D. Ringe, H. Faber, and A. Dorst Alendronate treatment of established primary osteoporosis in men: results of a 2-year prospective study J Clin Endocrinol Metab 86 2001 5252 5255
37. A.D. Walling Weekly therapy is effective in prevention of osteoporosis Am Fam Physician 68 2003 1212 1213
38. D.M. Reid, S. Adami, J.P. Devogelaer, and A.A. Chines Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy Calcif Tissue Int 69 2001 242 247
39. K. Johnson Consider raloxifene a safe alternative to HRT Family Practice News 30 2000 27 30
40. G.P. Trovas, G.P. Lyritis, and A. Galanos A randomized trial of nasal spray salmon calcitonin in men with idiopathic osteoporosis: effects on bone mineral density and bone markers J Bone Miner Res 17 2002 521 527
41. National Osteoporosis Foundation (NOF) National Osteoporosis Foundation comments on FDA approval of Forteo® 2004 National Osteoporosis Foundation Washington, DC
42. National Osteoporosis Foundation (NOF) Statement of the National Osteoporosis Foundation regarding FDA Committee's recommended approval of Forteo™ 2004 National Osteoporosis Foundation Washington, DC
43. C. LoBuona New osteoporosis drug is first to form bone Drug Topics 147 2003 24 25
44. National Osteoporosis Foundation (NOF) Pocket guide to prevention and treatment of osteoporosis 2003 National Osteoporosis Foundation Washington DC
45. K. Johnson Watchdog group issues warning against osteoporosis drug: expert questions legitimacy of claims Family Practice News 33 2003 6 10
46. D. Brunk Studies conflict on gastrointestinal event risk from bisphosphonates: alendronate vs. risedronate Internal Medicine News 3 2003 21 22
47. J.M. Campion, and M.J. Maricic Osteoporosis in men Am Fam Physician 67 2003 1521 1530
48. J.A. Kanis, O. Johnell, and A. Oden Diagnosis of osteoporosis and fracture threshold in men Calcif Tissue Int 69 2001 218 221
49. K.K. Kim, M.L. Horan, and P. Gendler Development and evaluation of the osteoporosis health belief scale Res Nurs Health 14 1991 155 163
50. G.H. Canty, F. Conde, and D.N. Rutledge Osteoporosis in men treated with androgen suppression therapy for prostate cancer Clinical Journal of Oncology Nursing 6 2002 88 103
51. D. Long Optimism for black men, women osteoporosis, and cancer sufferers Diagnostic & Imaging Week 5 2002 1 2
52. N.C. Binkley, and J.W. Suttie Vitamin K nutrition and osteoporosis J Nutr 125 1995 1812 1822
53. A.G. Juby, and P. Davis A prospective evaluation of the awareness, knowledge, risk factors and current treatment of osteoporosis in a cohort of elderly subjects Osteoporos Int 12 2001 617 622
54. Drug Information and Prices. Available at: http://www.walgreens.com. Accessed January 19, 2004.